These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11960398

  • 1. Sustained complete remission of chronic refractory immune thrombocytopenic purpura (ITP) of 10 years duration after only two infusions of rituximab.
    Cohen Y, Polliack A.
    Hematol J; 2002; 3(1):61-2. PubMed ID: 11960398
    [No Abstract] [Full Text] [Related]

  • 2. Rituximab is effective for selected patients with chronic steroid-refractory immune thrombocytopenic purpura.
    Lalayanni C, Stavroyianni N, Saloum R, Tsompanakou A, Anagnostopoulos A.
    Hematology; 2004 Aug; 9(4):287-9. PubMed ID: 15621736
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.
    Torii Y, Yagasaki H, Tanaka H, Mizuno S, Nishio N, Muramatsu H, Hama A, Takahashi Y, Kojima S.
    Int J Hematol; 2009 Sep; 90(2):174-176. PubMed ID: 19662467
    [Abstract] [Full Text] [Related]

  • 4. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.
    Parodi E, Nobili B, Perrotta S, Rosaria Matarese SM, Russo G, Licciardello M, Zecca M, Locatelli F, Cesaro S, Bisogno G, Giordano P, De Mattia D, Ramenghia U.
    Int J Hematol; 2006 Jul; 84(1):48-53. PubMed ID: 16867902
    [Abstract] [Full Text] [Related]

  • 5. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
    Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P.
    Blood; 2008 Aug 15; 112(4):999-1004. PubMed ID: 18463354
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.
    Pasa S, Altintas A, Cil T, Danis R, Ayyildiz O.
    J Thromb Thrombolysis; 2009 Apr 15; 27(3):329-33. PubMed ID: 18311541
    [Abstract] [Full Text] [Related]

  • 7. Rituximab for the treatment of acute refractory ITP.
    Kim SG, Whyte D, Pashankar FD.
    J Pediatr Hematol Oncol; 2014 Apr 15; 36(3):e149-51. PubMed ID: 23669737
    [Abstract] [Full Text] [Related]

  • 8. One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.
    Mueller BU, Bennett CM, Feldman HA, Bussel JB, Abshire TC, Moore TB, Sawaf H, Loh ML, Rogers ZR, Glader BE, McCarthy MC, Mahoney DH, Olson TA, Feig SA, Lorenzana AN, Mentzer WC, Buchanan GR, Neufeld EJ, Pediatric Rituximab/ITP Study Group, Glaser Pediatric Research Network.
    Pediatr Blood Cancer; 2009 Feb 15; 52(2):259-62. PubMed ID: 18937333
    [Abstract] [Full Text] [Related]

  • 9. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J, Majluf-Cruz A, Montiel-Cervantes L, Esparza MG, Vela-Ojeda J, Mexican Hematology Study Group.
    Ann Hematol; 2007 Dec 15; 86(12):871-7. PubMed ID: 17874322
    [Abstract] [Full Text] [Related]

  • 10. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.
    Giagounidis AA, Anhuf J, Schneider P, Germing U, Söhngen D, Quabeck K, Aul C.
    Eur J Haematol; 2002 Aug 15; 69(2):95-100. PubMed ID: 12366712
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D.
    Hematology; 2012 Apr 15; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [Abstract] [Full Text] [Related]

  • 12. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
    Stasi R, Pagano A, Stipa E, Amadori S.
    Blood; 2001 Aug 15; 98(4):952-7. PubMed ID: 11493438
    [Abstract] [Full Text] [Related]

  • 13. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct 15; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 14. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD, Madueme HL, Wolf RC, Tefferi A.
    Mayo Clin Proc; 2003 Nov 15; 78(11):1340-6. PubMed ID: 14601692
    [Abstract] [Full Text] [Related]

  • 15. Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura.
    Clausen MR, Segel E, Brandsborg M, d'Amore F.
    Eur J Haematol; 2011 Mar 15; 86(3):256-9. PubMed ID: 21166717
    [Abstract] [Full Text] [Related]

  • 16. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis.
    Thude H, Gruhn B, Werner U, Schorner U, Häfer R, Zintl F, Barz D.
    Acta Haematol; 2004 Mar 15; 111(4):221-4. PubMed ID: 15153715
    [Abstract] [Full Text] [Related]

  • 17. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y, Karapinar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker SA, Vergin C.
    Blood Coagul Fibrinolysis; 2016 Jun 15; 27(4):431-5. PubMed ID: 26656905
    [Abstract] [Full Text] [Related]

  • 18. Refractory autoimmune thrombocytopenic purpura treatment with Rituximab.
    Patel K, Berman J, Ferber A, Caro J.
    Am J Hematol; 2001 May 15; 67(1):59-60. PubMed ID: 11279663
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical therapeutic efficacy of rituximab for relapsed and refractory idiopathic thrombocytopenic purpura].
    Zhou LY, Zhang Z, Song LX, Gzhang X, Su JY, Li X, Chang CK.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug 15; 20(4):941-4. PubMed ID: 22931660
    [Abstract] [Full Text] [Related]

  • 20. Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.
    Pohlen M, Sargin B, Zicholl S, Bisping G, Müller-Tidow C, Berdel WE, Mesters R, Koschmieder S.
    Eur J Haematol; 2010 Apr 15; 84(4):362-4. PubMed ID: 20050881
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.